Start Date: 21/11/2013

End Date: 23/11/2013

Cost: Please see website

Venue: Wellcome Trust Conference Centre, Hinxton, Cambridge, UK


Wellcome Trust Scientific Conferences

Contact Details:

For more information please contact Jemma Beard on or call on +44 (0) 1223 495100


Abstract Deadline: 1 October 2013 Registration Deadline: 24 October 2013 The complete genome sequences of hundreds of organisms have provided the list of components required to make an organism viable. High-throughput functional genomic technologies continue to generate vast amounts of information describing the functions and interactions of these components within the cell. Through the combined use of computational and experimental techniques, we are achieving comprehensive mappings of cellular and molecular networks. However, there are major challenges to interpret these data in a biological meaningful fashion: how should we integrate these disparate data sources, and utilise them to improve our understanding of complex biological systems and diseases? The meeting will take place at the Wellcome Trust Conference Centre, in the convivial setting of the Hinxton Genome Campus where some of the world's leading scientists can discuss advances in their field and learn about recent progress in others. Additional speakers will be selected to speak from submitted abstracts Scientific Sessions This conference will provide a forum for discussions about post-genomic research in humans and other organisms. Rather than focusing on a particular subject, we will cover a diverse selection of areas in post-genomic science. Topics will include: - High throughput technologies and their applications - Functional genomics of disease and model organisms - Single cell/molecule level analysis - Genome regulation - Human genetic variation and disease - Visualisation and modelling of biological networks and pathways Scientific organising committee Alvis Brazma EMBL-EBI, UK Tom Freeman University of Edinburgh, UK Nicholas Luscombe University College London, UK Confirmed Speakers Ruedi Aebersold ETH Zurich, Institute of Molecular Systems Biology, Switzerland David Balding University College London, UK Peter Campbell Wellcome Trust Sanger Institute, UK Ron Germain National Institute of Allergy and infectious diseases, USA Suzana Hadjur University College London, UK Tom Hudson Ontario Institute for Cancer Research, Canada Paul Kellam Wellcome Trust Sanger Institute, UK Tuuli Lappalainen University of Geneva, Switzerland Duncan Odom Cancer Research UK Rikard Sandberg Karolinska Institutet, Sweden Timm Schroeder Institute of Stem Cell Research - Helmholtz Zentrum Muenchen, Germany Sarah Teichmann EMBL-EBI, UK Ashok Venkitaraman Fred Hutchinsons Institute, UK Mike White University of Manchester, UK